ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’
The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options
Laboratory Industry Report
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Subscribe today for access to
Articles and Reports
Out with the Old: The 2024 Clinical Lab Experience
What challenges and opportunities affected the experience of medical lab professionals in 2024—and what might the new year bring?
FDA Watch: How Could the Change in US Government Affect IVDs and Labs?
Experts say new leadership could impact the cost and availability of IVDs as well as patients’ ability to afford lab testing
One Blockbuster Dies and Another Arises as Sluggish Deal Making Continues
...
Already a member? Log in here
New Study to Evaluate Clinical Effectiveness of CRISPR SARS-CoV-2 Testing
...
Already a member? Log in here
Q2 Revenues Slide but By Less than Wall Street Expected
...
Already a member? Log in here
Telecommuter Home Office Hazard Assessment & Inspection Checklist
...
Already a member? Log in here
Saliva COVID-19 Tests Offer Way Around Nasopharyngeal Swab Shortage Bottlenecks
...
Already a member? Log in here
FDA Offers New Guidance on Validating SARS-CoV-2 Tests in “Non-Laboratory” Settings
...
Already a member? Log in here
Agency Green Lights First SARS-CoV-2 Tests for Sample Pooling
...
Already a member? Log in here
TOOL: Mandatory Mask and Face Covering Policy
...
Already a member? Log in here
